Geode Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $45.3M | Buy |
5,054,610
+93,973
| +2% | +$842K | ﹤0.01% | 1478 |
|
2025
Q1 | $37.2M | Buy |
4,960,637
+136,902
| +3% | +$1.03M | ﹤0.01% | 1550 |
|
2024
Q4 | $36.3M | Sell |
4,823,735
-14,250
| -0.3% | -$107K | ﹤0.01% | 1633 |
|
2024
Q3 | $36.8M | Buy |
4,837,985
+127,708
| +3% | +$971K | ﹤0.01% | 1623 |
|
2024
Q2 | $29.1M | Buy |
4,710,277
+310,006
| +7% | +$1.92M | ﹤0.01% | 1717 |
|
2024
Q1 | $22.4M | Buy |
4,400,271
+139,633
| +3% | +$709K | ﹤0.01% | 1863 |
|
2023
Q4 | $25.5M | Buy |
4,260,638
+349,561
| +9% | +$2.09M | ﹤0.01% | 1769 |
|
2023
Q3 | $27.7M | Buy |
3,911,077
+78,522
| +2% | +$556K | ﹤0.01% | 1616 |
|
2023
Q2 | $27M | Buy |
3,832,555
+178,999
| +5% | +$1.26M | ﹤0.01% | 1660 |
|
2023
Q1 | $30.5M | Buy |
3,653,556
+187,006
| +5% | +$1.56M | ﹤0.01% | 1524 |
|
2022
Q4 | $39.8M | Buy |
3,466,550
+100,706
| +3% | +$1.16M | 0.01% | 1311 |
|
2022
Q3 | $42.4M | Buy |
3,365,844
+83,687
| +3% | +$1.05M | 0.01% | 1198 |
|
2022
Q2 | $34.7M | Buy |
3,282,157
+179
| +0% | +$1.89K | 0.01% | 1364 |
|
2022
Q1 | $53.4M | Buy |
3,281,978
+63,502
| +2% | +$1.03M | 0.01% | 1211 |
|
2021
Q4 | $44.6M | Buy |
3,218,476
+78,977
| +3% | +$1.09M | 0.01% | 1387 |
|
2021
Q3 | $45.1M | Buy |
3,139,499
+26,937
| +0.9% | +$387K | 0.01% | 1369 |
|
2021
Q2 | $49.2M | Buy |
3,112,562
+122,039
| +4% | +$1.93M | 0.01% | 1322 |
|
2021
Q1 | $30.4M | Buy |
2,990,523
+334,394
| +13% | +$3.4M | ﹤0.01% | 1595 |
|
2020
Q4 | $19.8M | Buy |
2,656,129
+212,417
| +9% | +$1.58M | ﹤0.01% | 1725 |
|
2020
Q3 | $8.39M | Buy |
2,443,712
+232,959
| +11% | +$800K | ﹤0.01% | 2060 |
|
2020
Q2 | $10.5M | Buy |
2,210,753
+7,075
| +0.3% | +$33.7K | ﹤0.01% | 1901 |
|
2020
Q1 | $4.41M | Buy |
2,203,678
+293,274
| +15% | +$586K | ﹤0.01% | 2220 |
|
2019
Q4 | $6.59M | Buy |
1,910,404
+427,042
| +29% | +$1.47M | ﹤0.01% | 2287 |
|
2019
Q3 | $4.25M | Sell |
1,483,362
-3,237
| -0.2% | -$9.27K | ﹤0.01% | 2475 |
|
2019
Q2 | $5.63M | Buy |
1,486,599
+162,090
| +12% | +$614K | ﹤0.01% | 2312 |
|
2019
Q1 | $10.8M | Buy |
1,324,509
+96,746
| +8% | +$787K | ﹤0.01% | 1845 |
|
2018
Q4 | $9.91M | Buy |
1,227,763
+108,785
| +10% | +$878K | ﹤0.01% | 1795 |
|
2018
Q3 | $8.54M | Buy |
1,118,978
+115,482
| +12% | +$881K | ﹤0.01% | 2038 |
|
2018
Q2 | $5.75M | Buy |
1,003,496
+125,845
| +14% | +$721K | ﹤0.01% | 2248 |
|
2018
Q1 | $4.19M | Buy |
877,651
+58,236
| +7% | +$278K | ﹤0.01% | 2355 |
|
2017
Q4 | $4.02M | Buy |
819,415
+71,665
| +10% | +$352K | ﹤0.01% | 2326 |
|
2017
Q3 | $3.92M | Buy |
747,750
+93,166
| +14% | +$488K | ﹤0.01% | 2354 |
|
2017
Q2 | $3.64M | Sell |
654,584
-118,531
| -15% | -$659K | ﹤0.01% | 2366 |
|
2017
Q1 | $6.49M | Buy |
773,115
+255,975
| +49% | +$2.15M | ﹤0.01% | 1923 |
|
2016
Q4 | $3.27M | Buy |
517,140
+17,638
| +4% | +$112K | ﹤0.01% | 2330 |
|
2016
Q3 | $2.2M | Buy |
499,502
+6,062
| +1% | +$26.7K | ﹤0.01% | 2505 |
|
2016
Q2 | $1.4M | Sell |
493,440
-8,543
| -2% | -$24.3K | ﹤0.01% | 2713 |
|
2016
Q1 | $1.42K | Buy |
501,983
+25,331
| +5% | +$72 | ﹤0.01% | 2683 |
|
2015
Q4 | $4.92M | Buy |
476,652
+39,584
| +9% | +$409K | ﹤0.01% | 1888 |
|
2015
Q3 | $4.98M | Buy |
437,068
+31,052
| +8% | +$354K | ﹤0.01% | 1848 |
|
2015
Q2 | $6.06M | Buy |
406,016
+17,008
| +4% | +$254K | ﹤0.01% | 1770 |
|
2015
Q1 | $3.51M | Sell |
389,008
-30,897
| -7% | -$279K | ﹤0.01% | 2072 |
|
2014
Q4 | $5.11M | Buy |
419,905
+2,728
| +0.7% | +$33.2K | ﹤0.01% | 1803 |
|
2014
Q3 | $4.08M | Buy |
417,177
+48,137
| +13% | +$471K | ﹤0.01% | 1890 |
|
2014
Q2 | $4.71M | Buy |
369,040
+90,376
| +32% | +$1.15M | ﹤0.01% | 1826 |
|
2014
Q1 | $2.95M | Buy |
278,664
+57,029
| +26% | +$603K | ﹤0.01% | 2109 |
|
2013
Q4 | $1.68M | Buy |
221,635
+16,109
| +8% | +$122K | ﹤0.01% | 2405 |
|
2013
Q3 | $1.5M | Buy |
205,526
+32,927
| +19% | +$240K | ﹤0.01% | 2347 |
|
2013
Q2 | $268K | Buy |
+172,599
| New | +$268K | ﹤0.01% | 3129 |
|